+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Comparative activity of SCH 34343 against anaerobic bacteria



Comparative activity of SCH 34343 against anaerobic bacteria



Diagnostic Microbiology and Infectious Disease 4(4): 341-344



The in vitro activity of SCH 34343 was compared with that of imipenem, clindamycin, cefoxitin, and metronidazole against 78 strains of anaerobic bacteria in the presence and absence of blood. Wilkins-Chalgren agar was used. SCH 34343 and imipenem were the most active agents, inhibiting all strains at less than or equal to 8 micrograms/ml. The addition of blood had little effect on the activity of any of the agents. Seven strains were unable to grow on Wilkins-Chalgren agar. Even with the addition of blood, one strain each of Bacteroides asaccharolyticus and Bacteroides bivius and two strains of Fusobacterium were unable to grow. Sixty-eight of the strains were tested against SCH 34343 and imipenem on Brucella lysed blood agar. Minimal inhibitory concentrations tended to be somewhat higher on Brucella lysed blood agar than on Wilkins-Chalgren agar, and all strains were able to grow on Brucella lysed blood agar.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 039614462

Download citation: RISBibTeXText

PMID: 3698546

DOI: 10.1016/0732-8893(86)90075-1


Related references

Comparative in-vitro activity of Sch 34343 and other antimicrobial agents against anaerobic bacteria. Journal of Antimicrobial ChemoTherapy 15 Suppl C: 183-188, 1985

Comparative in-vitro activity of Sch 34343 for a wide spectrum of clinically significant anaerobic bacteria. Journal of Antimicrobial ChemoTherapy 15 Suppl C: 177-182, 1985

In-vitro activity of Sch 34343 against anaerobic bacteria. Journal of Antimicrobial ChemoTherapy 15 Suppl C: 173-176, 1985

In vitro activity of Sch 34343 and cefbuperazone against anaerobic bacteria. Antimicrobial Agents and ChemoTherapy 27(5): 749-752, 1985

Effect of medium, pH, and inoculum size on activity of ceftizoxime and Sch-34343 against anaerobic bacteria. Antimicrobial Agents and ChemoTherapy 30(4): 626-627, 1986

Susceptibility of anaerobic bacteria to Sch 34343 and other antibiotics. Journal of Antimicrobial ChemoTherapy 15 Suppl C: 193-198, 1985

Susceptibility of anaerobic bacteria to Sch 34343 and other beta-lactam antibiotics. Journal of Antimicrobial ChemoTherapy 15 Suppl C: 189-191, 1985

Comparative activity of the penem antibiotic Sch 34343 against gram-negative and gram-positive bacteria with special reference to multiresistant strains. Journal of Antimicrobial ChemoTherapy 15 Suppl C: 137-146, 1985

Comparative in vitro activity of PH-027 versus linezolid and other anti-anaerobic antimicrobials against clinical isolates of Clostridium difficile and other anaerobic bacteria. Journal of ChemoTherapy 15(2): 113-117, 2003

In vitro activity of Sch 34343 against enterococci and other gram-positive bacteria. Antimicrobial Agents and ChemoTherapy 27(1): 28-32, 1985

Comparative in-vitro activity of Sch 34343, a new penem antibiotic. Journal of Antimicrobial ChemoTherapy 15 Suppl C: 57-66, 1985

In-vitro activity of Sch 34343 against Gram-negative bacteria producing characterized beta-lactamases. Journal of Antimicrobial ChemoTherapy 15 Suppl C: 85-97, 1985

Comparative in vitro antibacterial activity of Sch 34343, a novel penem antibiotic. Antimicrobial Agents and ChemoTherapy 27(1): 128-131, 1985

Comparative in-vitro activity of Sch 34343, imipenem, cefpirome and cefotaxime. Journal of Antimicrobial ChemoTherapy 15 Suppl C: 155-164, 1985

Comparative in vitro activity of Sch 34343 against urea-splitting microorganisms. European Journal of Clinical Microbiology 4(6): 605-607, 1985